微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[57] 发布: 2013/08/27 06:32:28
多发性病灶可采用抗癌药物治疗,如氮芥、长春新碱、甲氨蝶呤或类固醇激素等药物。 【疗效标准及预后】 术后多可治愈,很少复发,预后良好。 转发分享: 分享到: ...
已读[55] 发布: 2013/08/27 06:32:24
对于经这些药物治疗失败的患者,替代药物较多,包括短期糖皮质激素、免疫调节疗法,如甲氨蝶呤和静脉注射免疫球蛋白。虽然这些药物中的任何一种均可能对患者有益,但...
已读[53] 发布: 2013/08/27 06:32:09
最常用的杀胚药物甲氨蝶呤(MTX)是一种化疗药,虽然用于宫外孕治疗的剂量要比化疗时小得多,但是如果病人的肝肾功能不好,药物打进去出不来的话,仍然会发生严重、...
已读[56] 发布: 2013/08/27 06:32:04
LifeNews.com The Court asked the Oklahoma Supreme Court to review the law and determine 1) whether the law prohibits the use of misoprostol to induce abortion, and 2) whether the law prohibits use of the drug methotrexate to treat ectopic pregnancies. The answer to  ... and more »
已读[51] 发布: 2013/08/27 06:31:55
New York Times We have learned that rapid responders to methotrexate (about 20 to 30 percent of patients) have excellent long-term function. We know that good long-ter...
已读[52] 发布: 2013/08/27 06:31:50
Pain Medicine News Simponi Aria Approved for Moderately to Severely Active RA. The FDA has approved Simponi Aria (golimumab; Janssen) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) in combination with methotrexate .
已读[55] 发布: 2013/08/27 06:31:42
Standard Newswire (press release) Based upon the existing state of medical knowledge, the law is rationally related to the protection of a pregnant woman's health and neither bans the use of misoprostol nor restricts the use of methotrexate in the treatment of an ectopic pregnancy ... and more »
已读[49] 发布: 2013/08/27 06:31:36
WebMD.Boots.com Across the four groups taking methotrexate plus mavrilimumab, about 56 in 100 people had met the target reduction in DAS-28, compared with 35 in 100 people taking methotrexate plus placebo. When the researchers broke the figures down between the four  ...
已读[52] 发布: 2013/08/27 06:31:31
Luton Today The focus will be on Methotrexate and biologic treatments for the condition, giving an idea of the vast range of medication available. The pharmacy team will also be manning a stand to discuss medication on a one-to-one basis. Refreshments will be ...
已读[53] 发布: 2013/08/27 06:31:26
Everyday Health Tofacitinib, a Janus kinase inhibitor, improved disease control in patients with active RA despite treatment with nonbiologic DMARDs, primarily methotrexate , a study found. By Crystal Phend, Senior Staff Writer, MedPage Today. Reviewed by Zalman S ...
« 上一页  |   查看结果11-20共335   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘